| J9271 | Injection, pembrolizumab, 1 mg | 12,500 | $40 | $537.5K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 7,020 | $40 | $266.8K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,690 | $20 | $56.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $100 | $38.6K |
| J0897 | Injection, denosumab, 1 mg | 1,860 | $20 | $33.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $90 | $22.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 240 | $60 | $15.4K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 180 | $70 | $12.6K |
| J0185 | Injection, aprepitant, 1 mg | 12,480 | $1 | $12.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 90 | $140 | $12.2K |